Manna X. Li

No. 1, Minde Road
Nanchang, 330006, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Glycine decarboxylase advances IgA nephropathy by boosting mesangial cell proliferation through the pyrimidine pathway.

Glycine decarboxylase advances IgA nephropathy by boosting mesangial cell proliferation through the pyrimidine pathway.

Journal: EMBO molecular medicine

Published: March 31, 2025

Evaluation of immunotherapy for idiopathic membranous nephropathy based on risk stratification and pathological stage.

Evaluation of immunotherapy for idiopathic membranous nephropathy based on risk stratification and pathological stage.

Journal: European journal of pharmacology

Published: February 23, 2025

Dapagliflozin in diabetic kidney disease patients with different filtration status.

Dapagliflozin in diabetic kidney disease patients with different filtration status.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: October 28, 2024

Efficacy and safety of Kunxian in IgA nephropathy.

Efficacy and safety of Kunxian in IgA nephropathy.

Journal: Frontiers in pharmacology

Published: September 20, 2024

Diabetic kidney disease: m6A modification as a marker of disease progression and subtype classification.

Diabetic kidney disease: m6A modification as a marker of disease progression and subtype classification.

Journal: Frontiers in medicine

Published: September 10, 2024

Comparison of the Effects of SGLT-2i Versus GLP-1RA on Cardiovascular and Renal Outcomes in Patients With Type 2 Diabetes, Based on Baseline Renal Function.

Comparison of the Effects of SGLT-2i Versus GLP-1RA on Cardiovascular and Renal Outcomes in Patients With Type 2 Diabetes, Based on Baseline Renal Function.

Journal: Diabetes

Published: August 14, 2024

Combination of rituximab and short-term glucocorticoids in the treatment of anti-phospholipase A2 receptor antibody positive idiopathic membranous nephropathy.

Combination of rituximab and short-term glucocorticoids in the treatment of anti-phospholipase A2 receptor antibody positive idiopathic membranous nephropathy.

Journal: Clinical and experimental medicine

Published: August 13, 2023

Correction to: METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of α‑klotho.

Correction to: METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of α‑klotho.

Journal: Molecular medicine (Cambridge, Mass.)

Published: January 25, 2022

The pathogenesis of amyotrophic lateral sclerosis: Mitochondrial dysfunction, protein misfolding and epigenetics.

The pathogenesis of amyotrophic lateral sclerosis: Mitochondrial dysfunction, protein misfolding and epigenetics.

Journal: Brain research

Published: November 25, 2021

An update of proliferative glomerulonephritis with monoclonal immunoglobulin deposits.

An update of proliferative glomerulonephritis with monoclonal immunoglobulin deposits.

Journal: Clinical kidney journal

Published: July 07, 2021

METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of α-klotho.

METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of α-klotho.

Journal: Molecular medicine (Cambridge, Mass.)

Published: May 14, 2021

Clinical efficacy and safety of different tacrolimus concentrations for the treatment of patients with idiopathic membranous nephropathy.

Clinical efficacy and safety of different tacrolimus concentrations for the treatment of patients with idiopathic membranous nephropathy.

Journal: Scientific reports

Published: October 30, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026